DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trelstar (Triptorelin Pamoate) - Current Clinical Trials

 
 



Trelstar Related Clinical Trials

Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI [Recruiting]

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer [Terminated]

Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls [Active, not recruiting]

Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty [Completed]

Triptorelin for Ovary Protection in Childhood Onset Lupus [Completed]

Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer [Completed]

Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer [Completed]

HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. [Recruiting]

A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. [Recruiting]

Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty [Completed]

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg [Completed]

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism [Active, not recruiting]

Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT) [Terminated]

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer [Terminated]

Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin [Completed]

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study [Active, not recruiting]

Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer [Completed]

TRial on the Endocrine Activity of Neoadjuvant Degarelix [Recruiting]

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer [Completed]

Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome [Recruiting]

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery [Completed]

Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02 [Active, not recruiting]

Study to Evaluate a Subcutaneous Four Months Sustained-Release Formulation of Triptorelin in Patients With Prostate Cancer [Terminated]

Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure [Active, not recruiting]

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer [Terminated]

High-Dose Brachytherapy in Treating Patients With Prostate Cancer [Recruiting]

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 [Active, not recruiting]

A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703) [Completed]

Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients [Recruiting]

Luteal Phase Plus GnRH-agonist After GnRH-agonist Triggering Combined With Low Dose HCG in IVF (LPGGTHI) [Recruiting]

GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study [Completed]

Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval [Recruiting]

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Recruiting]

Endometrial Receptivity After GnRH Agonist Triggering [Recruiting]

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer [Recruiting]

Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer [Not yet recruiting]

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration [Completed]

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients [Completed]

Micro RNAs to Predict Response to Androgen Deprivation Therapy [Recruiting]

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve [Recruiting]

A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height [Recruiting]

Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF [Recruiting]

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer [Recruiting]

The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes [Recruiting]

A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months [Recruiting]

Suppression of Ovarian Function and Either Tamoxifen or Exemestane With or Without Chemotherapy in Treating Premenopausal Women With Resected Breast Cancer [Terminated]

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783) [Completed]

Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF [Recruiting]

Administration of GnRH Antagonist to Oocyte Donation Recipients [Completed]

GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles [Recruiting]

GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles [Recruiting]

Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery [Recruiting]

The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer [Recruiting]

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy [Completed]

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy [Completed]

Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days [Completed]

The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis [Completed]

Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles [Terminated]

GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles [Completed]

Hormone Therapy in Treating Patients With Advanced Prostate Cancer [Completed]

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer [Recruiting]

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]

GP Extended Action Triptorelin [Completed]

Multidisciplinary Study of Androgen Deprivation Therapy (ADT) in Prostate Cancer [Recruiting]

GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation [Recruiting]

Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG [Active, not recruiting]

Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children [Recruiting]

GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer [Recruiting]

Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial [Recruiting]

Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients [Recruiting]

Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome [Recruiting]

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer [Recruiting]

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse [Active, not recruiting]

Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women [Recruiting]

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients [Recruiting]

Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation [Recruiting]

Hypo-fractionated Proton Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer [Recruiting]

Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression [Not yet recruiting]

IVF/ICSI Protocols in Poor Responders With Growth Hormone [Recruiting]

Long Protocol in Poor Responders [Recruiting]

Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration [Recruiting]

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 [Active, not recruiting]

A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel [Active, not recruiting]

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients [Terminated]

Microflare Protocol in Poor Responders [Completed]

Oral Contraceptive Pill and GnRH Antagonist Versus Long Protocol in IVF Patients [Completed]

Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors [Completed]

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer [Terminated]

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer [Completed]

Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients [Recruiting]

Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017